- Home
- BBD vs WST Comparison
BBD vs WST Comparison
Compare BBD & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBD
- WST
- Stock Information
- Founded
- BBD 1943
- WST 1923
- Country
- BBD Brazil
- WST United States
- Employees
- BBD N/A
- WST N/A
- Industry
- BBD Major Banks
- WST Medical/Dental Instruments
- Sector
- BBD Finance
- WST Health Care
- Exchange
- BBD Nasdaq
- WST Nasdaq
- Market Cap
- BBD 30.6B
- WST 18.0B
- IPO Year
- BBD N/A
- WST N/A
- Fundamental
- Price
- BBD $3.25
- WST $267.95
- Analyst Decision
- BBD Strong Buy
- WST Strong Buy
- Analyst Count
- BBD 4
- WST 8
- Target Price
- BBD $2.55
- WST $333.71
- AVG Volume (30 Days)
- BBD 62.2M
- WST 623.0K
- Earning Date
- BBD 10-29-2025
- WST 10-23-2025
- Dividend Yield
- BBD 5.16%
- WST 0.33%
- EPS Growth
- BBD 58.81
- WST N/A
- EPS
- BBD 0.36
- WST 6.68
- Revenue
- BBD $16,114,445,927.00
- WST $2,960,200,000.00
- Revenue This Year
- BBD $77.46
- WST $6.28
- Revenue Next Year
- BBD $7.42
- WST $6.11
- P/E Ratio
- BBD $8.03
- WST $39.34
- Revenue Growth
- BBD 27.09
- WST 2.90
- 52 Week Low
- BBD $1.84
- WST $187.43
- 52 Week High
- BBD $3.41
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- BBD 55.61
- WST 58.10
- Support Level
- BBD $3.04
- WST $257.50
- Resistance Level
- BBD $3.20
- WST $265.66
- Average True Range (ATR)
- BBD 0.08
- WST 5.74
- MACD
- BBD -0.01
- WST -0.78
- Stochastic Oscillator
- BBD 55.41
- WST 49.62
About BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.